Guidance for Axovant Sciences Ltd. (AXON)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2025 | N/A | N/A | $2.74B | $2.72B | = Maintained | Details |
| 2025 | N/A | N/A | $2.65B – 2.73B | $2.66B | = Maintained | Details |
| 2025 | N/A | N/A | $2.60B – 2.70B | $2.62B | = Maintained | Details |
| 2025 | N/A | N/A | $2.55B – 2.65B | $2.56B | = Maintained | Details |
| 2024 | N/A | N/A | $2.07B | $2.04B | = Maintained | Details |
| 2024 | N/A | N/A | $2.00B – 2.05B | $1.98B | = Maintained | Details |
| 2024 | N/A | N/A | $1.94B – 1.99B | $1.93B | = Maintained | Details |
| 2024 | N/A | N/A | $1.88B – 1.94B | $1.88B | = Maintained | Details |
| Q4 2024 | N/A | N/A | $560.00M – 570.00M | $547.00M | = Maintained | Details |
| 2023 | N/A | N/A | $1.55B | $1.53B |  Raised |
Details |
| 2023 | N/A | N/A | $1.51B – 1.53B | $1.46B | Raised |
Details |
| 2023 | N/A | N/A | $1.44B – 1.46B | $1.44B | Raised |
Details |
| 2023 | N/A | N/A | $1.43B | $1.38B | = Maintained | Details |
| 2022 | N/A | N/A | $1.15B – 1.16B | $1.11B | = Maintained | Details |
| 2022 | N/A | N/A | $1.07B – 1.12B | $1.08B | = Maintained | Details |
| 2022 | N/A | N/A | $1.05B – 1.10B | $1.05B | = Maintained | Details |
| Q4 2022 | N/A | N/A | $300.00M – 310.00M | $287.30M | = Maintained | Details |
| 2021 | N/A | N/A | $825.00M – 850.00M | $806.00M | = Maintained | Details |
| 2021 | N/A | N/A | $740.00M – 780.00M | $742.24M | Raised |
Details |
| Q2 2021 | N/A | N/A | $780.00M – 820.00M | $760.61M | Raised |
Details |
